Dose Escalation Study of SQ109 in Healthy Adult Volunteers

NCT00866190 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

TB Multi-drug Resistant

Interventions

DRUG: SQ109
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)